St Jude Medical’s CardioMEMS HF System recommended in new ESC guidelines

St Jude Medical has announced that its CardioMEMS HF System has been recommended in new treatment guidelines from the European Society of Cardiology (ESC).

The new 2016 ESC Clinical Practice Guidelines for the diagnosis and treatment of acute and chronic heart failure have included pulmonary artery pressure monitoring with the CardioMEMS HF System as a directed therapy management and monitoring tool for heart failure patients.

Clinical data from the CHAMPION study was used to establish this Class IIb recommendation for the system. It applies to all Class III heart failure patients regardless of their ejection fraction.

Dr Philip Adamson, medical director and vice-president of medical affairs for St Jude Medical, said: "We are very pleased to see the CardioMEMS HF System was included in the guidelines, and congratulate the European Society of Cardiology for working to make this technology more widely available to benefit patients living with heart failure."

The CardioMEMS HF System is the first and only CE Mark-approved heart failure monitor that has been shown to significantly reduce heart failure hospital admissions and improve quality of life for these patients.